Predictive biomarkers in cancer therapy
US7794960B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2005 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Aug 3, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57415
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The use of various biomarkers to assess a subject's suitability for treatment with a EGFR/ErbB2 kinase inhibitor for a solid tumor are described. The biomarkers include TGFalpha, pS6, IGF-1R and levels of apoptosis occurring in tumor tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.